ArticleCNS & neurological disorders drug targets2014
Commentary: research highlights: Inflammation, demyelination and neurodegeneration: risky buddies in multiple sclerosis.
Susanna Amadio et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it